Montag A & Associates Inc. Has $8.72 Million Stock Position in SPDR S&P Biotech ETF $XBI

Montag A & Associates Inc. lifted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 68,236 shares of the exchange traded fund’s stock after acquiring an additional 12,089 shares during the quarter. Montag A & Associates Inc.’s holdings in SPDR S&P Biotech ETF were worth $8,716,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in XBI. Morgan Stanley increased its position in SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after purchasing an additional 882,718 shares during the period. Wells Fargo & Company MN boosted its stake in shares of SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares during the last quarter. Avoro Capital Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $256,053,000. Bessemer Group Inc. grew its position in shares of SPDR S&P Biotech ETF by 13.5% during the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock worth $225,965,000 after buying an additional 220,244 shares during the period. Finally, Ameriprise Financial Inc. raised its stake in shares of SPDR S&P Biotech ETF by 40.5% during the third quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock worth $122,906,000 after buying an additional 353,351 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $163.87 on Wednesday. The company has a fifty day moving average price of $138.55 and a two-hundred day moving average price of $130.59. SPDR S&P Biotech ETF has a 52 week low of $83.45 and a 52 week high of $164.35. The firm has a market capitalization of $11.16 billion, a PE ratio of 11.47 and a beta of 0.82.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.